Suven Life Sciences - Quaterly Results

09 May 2023 Evaluate
The sales is pegged at Rs. 26.11 millions for the March 2023 quarter. The mentioned figure indicates a decline of about -38.14% as against Rs. 42.21 millions during the year-ago period.The Net Loss for the quarter ended March 2023 is Rs. -22.50 millions as compared to Net Loss of Rs. -85.54 millions of corresponding quarter ended March 2022 Operating profit Margin for the quarter ended March 2023 improved to -5.24% as compared to -73.54% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 26.11 42.21 -38.14 135.39 118.44 14.31 135.39 118.44 14.31
Other Income 56.02 1.18 4647.46 84.49 16.01 427.73 84.49 16.01 427.73
PBIDT -5.24 -73.54 -92.87 -192.95 -350.41 -44.94 -192.95 -350.41 -44.94
Interest 0.54 0.98 -44.90 2.89 5.30 -45.47 2.89 5.30 -45.47
PBDT -5.78 -74.52 -92.24 -135.84 -318.55 -57.36 -135.84 -318.55 -57.36
Depreciation 16.72 11.02 51.72 65.43 43.93 48.94 65.43 43.93 48.94
PBT -22.50 -85.54 -73.70 -201.27 -362.48 -44.47 -201.27 -362.48 -44.47
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -22.50 -85.54 -73.70 -201.27 -362.48 -44.47 -201.27 -362.48 -44.47
Equity 218.07 145.38 50.00 218.07 145.38 50.00 218.07 145.38 50.00
PBIDTM(%) -20.07 -174.22 -88.48 -142.51 -295.85 -51.83 -142.51 -295.85 -51.83

Suven Life Sciences Share Price

147.80 -2.35 (-1.57%)
19-Jan-2026 12:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1683.20
Dr. Reddys Lab 1175.30
Cipla 1392.30
Zydus Lifesciences 870.00
Lupin 2180.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×